Verastem reported $6.42M in Selling and Administration Expenses for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Abbvie ABBV:US USD 3.22B 86M
AstraZeneca AZN:LN USD 3.35B 280M
Curis CRIS:US USD 9.11M 4.02M
Cytokinetics CYTK:US USD 48.22M 5.51M
Gilead Sciences GILD:US USD 2.02B 807M
Immunogen IMGN:US USD 33.62M 9.83M
Laboratory Of America LH:US USD 510M 24M
Novartis NOVN:VX USD 3.4B 185M
Pfizer PFE:US USD 4.87B 1.33B
Roche Holding ROG:VX 5.64B 899M
Tg Therapeutics TGTX:US USD 14.25M 1.62M
Verastem VSTM:US USD 6.42M 93K
YTE INCY:US USD 266.46M 13.18M
Ziopharm Oncology ZIOP:US USD 3.28M 147K